You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Baxter
McKesson
Express Scripts
Johnson and Johnson

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

AbbVie Inc. v. Hetero USA Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-10-02
Court District Court, D. Delaware Date Terminated 2015-10-27
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ABBVIE DEUTSCHLAND GMBH & CO. KG; ABBVIE INC.; HETERO LABS LIMITED; HETERO LABS LIMITED UNIT-III; HETERO USA INC.
Patents 6,037,157; 6,703,403; 7,148,359; 7,364,752; 8,025,899; 8,268,349; 8,309,613; 8,377,952; 8,399,015; 8,470,347; 8,691,878
Attorneys Derek James Fahnestock; Mary B. Graham; Stephen J. Kraftschik
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in AbbVie Inc. v. Hetero USA Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-10-02 1 civil action for patent infringement of: (1) United States Patent Number 6,037,157 B1 as amended by … known as Number 6,037,157 C1 (together “the ’157 Patent”); (2) United States Patent Number 6,703,403…Certificate, which amended the ’157 Patent as United States Patent Number 6,037,157 C1. AbbVie Inc. is the owner…B2 (“the ’403 Patent”); (3) United States Patent Number 7,148,359 B2 (“the ’359 Patent”); (4) United …together “the ’752 Patent”); (5) United States Patent Number 8,025,899 (“the ’899 Patent”); (6) United States External link to document
2015-10-27 7 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,037,157; 6,703,403; 7,148,359…2015 27 October 2015 1:15-cv-00889 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.